As filed with the Securities and Exchange Commission on March 17, 2009
Registration No. 333-116589
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 2
TO
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ABBOTT MEDICAL OPTICS INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware |
|
33-0986820 |
1700 E. St. Andrew Place
Santa Ana, California 92705
(714) 247-8200
(Address, Including Zip Code, and Telephone Number, Including
Area Code, of Registrants Principal Executive Offices)
Aimee S. Weisner
Executive Vice President, Administration and Secretary
1700 E. St. Andrew Place
Santa Ana, California 92705
(714) 247-8200
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, Of Agent For Service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer, and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer x |
|
Accelerated filer o |
Non-accelerated filer o
|
|
Smaller reporting company o |
DEREGISTRATION OF SECURITIES
On June 17, 2004, Advanced Medical Optics, Inc., a Delaware corporation (AMO), filed a registration statement on Form S-8 (Registration No. 333-116589) (the Registration Statement) with the U.S. Securities and Exchange Commission with respect to a total of 2,000,000 shares of AMO common stock, par value $0.01 per share (the Common Stock), issuable by AMO under the Advanced Medical Optics, Inc. 2002 Incentive Compensation Plan (the Plan), including rights to purchase Series A junior participating preferred stock of AMO, which are attached to all shares of AMO Common Stock in accordance with the Rights Agreement, dated June 24, 2002, by and between AMO and Mellon Investor Services, LLC. The Registration Statement also automatically covered any additional shares of Common Stock that become issuable under the Plan by reason of any stock dividend, stock split, or other similar transaction.
On February 26, 2009, pursuant to the Agreement and Plan of Merger, dated as of January 11, 2009, among AMO, Abbott Laboratories, an Illinois corporation (Parent), and Rainforest Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Parent (Merger Sub), Merger Sub merged with and into AMO (the Merger), with AMO surviving the Merger as a wholly owned subsidiary of Parent. Concurrently with the Merger, AMO changed its name to Abbott Medical Optics Inc. (the Company). As a result of the Merger, AMOs Common Stock is no longer publicly traded. Accordingly, the Company wishes to terminate the offering of securities registered pursuant to the Registration Statement.
Pursuant to the undertaking made by AMO in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering, the Company is filing this Post-Effective Amendment No. 2 to the Registration Statement to terminate the effectiveness of such Registration Statement and to deregister all of the shares of Common Stock that remain unsold as of the date hereof.
2
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 2 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Santa Ana, State of California, on March 17, 2009.
|
Abbott Medical Optics Inc. |
||
|
|
||
|
By: |
/s/ Aimee S. Weisner |
|
|
|
Name: |
Aimee S. Weisner |
|
|
Title: |
Executive Vice President, Administration and Secretary |
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:
Signature |
|
Title |
|
Date |
|
|
|
|
|
|
|
|
|
|
* |
|
Chief Executive Officer |
|
March 17, 2009 |
James V. Mazzo |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/ Michael V. Lambert |
|
Executive Vice President and Chief |
|
March 17, 2009 |
Michael V. Lambert |
|
Financial Officer (Principal Financial Officer) |
|
|
|
|
|
|
|
* |
|
Senior Vice President, Chief Accounting |
|
March 17, 2009 |
Robert F. Gallagher |
|
Officer and Controller |
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Thomas C. Freyman |
|
Director |
|
March 17, 2009 |
Thomas C. Freyman |
|
|
|
|
* By: |
/s/ Aimee S. Weisner |
|
|
|
Aimee S. Weisner |
|
|
|
As attorney-in-fact under power of attorney granted in Registration Statement previously filed on June 17, 2004 |
|
3